Considering that insulin resistance is an underlying mechanism of type 2 DM and cognition impairment, and that adiponectin improves insulin signaling and glucose uptake, we suggest that the determination of this adipocytokine level could help to detect at-risk individuals before advanced age, in presymptomatic stages of the diseases. The gene discussed is ADIPOQ; the disease is Cognitive impairment.